About 462,000 results
Any time
Open links in new tab
Federal Trade Commission sues drug 'gatekeepers'
✕About this result- This title and these news articles are related to your search term(s).
- Articles come from a variety of sources across the web.
- Titles are algorithmically generated based on content related to your search term(s).
- People also ask
- Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower list price products, and shifted the cost of high insulin list prices to vulnerable patients.www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-dr…
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
See results only from ftc.govFTC Releases Interim Staff Re…
The Federal Trade Commission today published an interim report on the …
Pharmacy Benefit Managers: …
Visit the Noncompetes feature page for more information, including factsheets …
FTC sues pharmacy benefit managers for inflating price of insulin : …
Federal Trade Commission sues largest drug middlemen for ... - CNN
Federal Trade Commission accuses three drug middlemen of …
FTC Releases Interim Staff Report on Prescription Drug Middlemen
Pharmacy Benefit Managers: The Powerful Middlemen Inflating …
F.T.C. Slams Middlemen for High Drug Prices - The …
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating...
FTC Sues Pharmacy Benefit Managers for Inflating Insulin Prices
Pharmacy benefit managers profit at expense of patients and …
FTC sues insulin middlemen, saying they pocket billions while …